An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

NCT05411211 · clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie